Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

U.S. drugmakers Johnson & Johnson and Eli Lilly increased spending on security for their top executives in 2024, citing ...

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.

Eli Lilly CEO Dave Ricks made $114 million last year, according to a new proxy statement, a rare instance of a health executive pulling in nine figures in a single year. Lilly also disclosed about ...

Top holdings in the Vanguard Consumer Staples ETF(NYSEMKT: VDC) include retailers like Costco Wholesale and Walmart, ...

The University of Copenhagen is excited to announce Maxwell Biosciences as Tier 1 Sponsor of the 12th Aging Research & Drug ...

Companies like Novo Nordisk, Boeing, and Walmart are preparing for the impacts of President Donald Trumps tariffs. Executives ...

Cristina Arias / Cover / Getty Images Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly ... Roche CEO Teresa Graham said the drugmaker hopes ...

Eli Lilly CEO Dave Ricks made $114 million in 2024, according to a new proxy statement to investors, putting him in the rare company of health care executives who have pulled in at least nine ...